The effect of multispot laser panretinal photocoagulation on retinal sensitivity and driving eligibility in patients with diabetic retinopathy

JAMA Ophthalmology

Volumn 134, Issue 6, 2016, Pages 666-672

  Subash, Mala ^a   Comyn, Oliver ^a   Samy, Ahmed ^a   Qatarneh, Dania ^a   Antonakis, Serafeim ^a   Mehat, Manjit ^a   Tee, James ^a   Mansour, Tatiana ^a   Xing, Wen ^a   Bunce, Catey ^a   Viswanathan, Ananth ^a   Rubin, Gary ^a   Weleber, Richard ^b   Peto, Tunde ^a   Wickham, Louisa ^a   Michaelides, Michel ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMPHREY PERIMETER; INSULIN DEPENDENT DIABETES MELLITUS; INTERVENTION STUDY; LASER COAGULATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; PANRETINAL PHOTOCOAGULATION; PERIMETRY; PHOTOTHERAPY DEVICE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA FLUORESCEIN ANGIOGRAPHY; TERTIARY CARE CENTER; CAR DRIVING; FLUORESCENCE ANGIOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RETINA; UNITED KINGDOM; VISUAL ACUITY; VISUAL FIELD;

ADULT; AUTOMOBILE DRIVING; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; LASER COAGULATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; UNITED KINGDOM; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84973862710     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2016.0629     Document Type: Article

References (23)

1. The Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol. 1976;81(4):383-396.
2. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: the second report of Diabetic Retinopathy Study findings. Ophthalmology. 1978;85(1):82-106.
3. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity: Diabetic Retinopathy Study report no. 5. Dev Ophthalmol. 1981;2:248-261.
4. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report number 8. Ophthalmology. 1981;88(7):583-600.
5. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy: ETDRS report number 9. Ophthalmology. 1991;98(5) (suppl):766-785.
6. Mackie SW, Webb LA, Hutchison BM, Hammer HM, Barrie T, Walsh G. How much blame can be placed on laser photocoagulation for failure to attain driving standards? Eye (Lond). 1995;9(pt 4):517-525.
7. Hulbert MF, Vernon SA. Passing the DVLC field regulations following bilateral pan-retinal photocoagulation in diabetics. Eye (Lond). 1992;6(pt 5):456-460.
8. Williamson TH, George N, Flanagan DW, Norris V, Blamires T. Driving Standards: Visual Fields in Diabetic Patients After Pan-retinal Photocoagulation: Vision in Vehicles III. Amsterdam, the Netherlands: North-Holland/Elsevier; 1991:265-272.
9. Buckley SA, Jenkins L, Benjamin L. Fields, DVLC and panretinal photocoagulation. Eye (Lond). 1992;6(pt 6):623-625.
10. Pearson AR, Tanner V, Keightley SJ, Casswell AG. What effect does laser photocoagulation have on driving visual fields in diabetics? Eye (Lond). 1998;12(pt 1):64-68.
11. Muqit MM, Wakely L, Stanga PE, Henson DB, Ghanchi FD. Effects of conventional argon panretinal laser photocoagulation on retinal nerve fibre layer and driving visual fields in diabetic retinopathy. Eye (Lond). 2010;24(7):1136-1142.
12. Gross JG, Glassman AR, Jampol AR, et al; Writing Committee for the Diabetic Retinopathy Clinical Research Network. Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA. 2015;314(20):2137-2146.
13. Drivers Medical Group. At a Glance Guide to the Current Medical Standards of Fitness to Drive. Swansea, Wales: Driver Vehicle and Licensing Agency; 2013.
14. Colenbrander A, De Laey J. Visual standards: vision requirements for driving safety. http://www.icoph.org/downloads/visionfordriving.pdf. Published December 2005. Accessed January 21, 2016.
15. Sanghvi C, McLauchlan R, Delgado C, et al. Initial experience with the Pascal photocoagulator: a pilot study of 75 procedures. Br J Ophthalmol. 2008;92(8):1061-1064.
16. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194. doi:10.1001/jama.2013.281053.
17. Luithardt AF, Meisner C, Monhart M, Krapp E, Mast A, Schiefer U. Validation of a new static perimetric thresholding strategy (GATE). Br J Ophthalmol. 2015;99(1):11-15.
18. Massof RW, Ahmadian L, Grover LL, et al. The Activity Inventory: an adaptive visual function questionnaire. Optom Vis Sci. 2007;84(8):763-774.
19. Weleber RG, Smith TB, Peters D, et al. VFMA: topographic analysis of sensitivity data from full-field static perimetry. Transl Vis Sci Technol. 2015;4(2):14.
20. Maeshima K, Utsugi-Sutoh N, Otani T, Kishi S. Progressive enlargement of scattered photocoagulation scars in diabetic retinopathy. Retina. 2004;24(4):507-511.
21. Mainster MA, Sliney DH, Belcher CD III, Buzney SM. Laser photodisruptors: damage mechanisms, instrument design and safety. Ophthalmology. 1983;90(8):973-991.
22. Younis N, Broadbent DM, Vora JP, Harding SP; Liverpool Diabetic Eye Study. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet. 2003;361(9353):195-200.
23. Younis N, Broadbent DM, Harding SP, Vora JP. Incidence of sight-threatening retinopathy in type 1 diabetes in a systematic screening programme. Diabet Med. 2003;20(9):758-765.